Blood Biomarkers as Surrogate Endpoints of Treatment Responses to Aerobic Exercise and /or Cognitive Training in Amnestic Mild Cognitive Impairment

Project: Research project

Project Details

Description

Blood Biomarkers as Surrogate Endpoints of Treatment Responses to Aerobic Exercise and /or Cognitive Training in Amnestic Mild Cognitive Impairment Blood Biomarkers as Surrogate Endpoints of Treatment Responses to Aerobic Activity
StatusActive
Effective start/end date2/1/215/31/22

Funding

  • HHS: National Institutes of Health (NIH): $113,187.00

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.